Drug information provided by: Merative, Micromedex®
Eflornithine is used to reduce the risk of relapse (coming back) in patients with high-risk neuroblastoma (a type of cancer that most often occurs in young children) who have had at least a partial response to previous treatment (eg, anti-GD2 immunotherapy).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.